CORC

浏览/检索结果: 共42条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 15, 期号: 3
作者:  He, Dalin;  Sun, Zhongquan;  Guo, Jianming;  Zhang, Zhigen;  Shan, Yuxi
收藏  |  浏览/下载:37/0  |  提交时间:2019/12/05
Clinical activity of abiraterone plus prednisone in docetaxel-naive and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2019, 卷号: 21, 期号: 2
作者:  Lin, Guo-Wen;  Li, Gao-Xiang;  Dai, Bo;  Ye, Ding-Wei;  Kong, Yun-Yi
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/05
Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2019-05-01
作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong
收藏  |  浏览/下载:31/0  |  提交时间:2020/01/03
Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文
2019, 卷号: 60
作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong
收藏  |  浏览/下载:35/0  |  提交时间:2020/01/03
First-in-human study of Lu-177-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文
2019, 卷号: 46, 期号: 1, 页码: 148-158
作者:  Zang, Jie;  Fan, Xinrong;  Wang, Hao;  Liu, Qingxing;  Wang, Jingnan
收藏  |  浏览/下载:27/0  |  提交时间:2020/01/03
Pretherapeutic Ga-68-PSMA-617 PET May Indicate the Dosimetry of Lu-177-PSMA-617 and Lu-177-EB-PSMA-617 in Main Organs and Tumor Lesions 期刊论文
2019, 卷号: 44, 期号: 6, 页码: 431-438
作者:  Wang, Jingnan;  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Li, Fang
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China 期刊论文
2019, 卷号: 15, 期号: 3, 页码: 144-150
作者:  He, Dalin;  Sun, Zhongquan;  Guo, Jianming;  Zhang, Zhigen;  Shan, Yuxi
收藏  |  浏览/下载:22/0  |  提交时间:2020/01/03
Serum neuroendocrine markers predict therapy outcome of patients with metastatic castration-resistant prostate cancer: A meta-Analysis 期刊论文
UROLOGIA INTERNATIONALIS, 2019, 卷号: 102, 期号: 4, 页码: 373-384
作者:  Liu, Yangzhou;  Zhao, Shankun;  Wang, Jiamin;  Zhu, Zhiguo;  Luo, Lianmin
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/27
External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2018, 卷号: 20, 期号: 2
作者:  Yang, Yun-Jie;  Lin, Guo-Wen;  Li, Gao-Xiang;  Dai, Bo;  Ye, Ding-Wei
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/05
Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study 期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2018, 卷号: Vol.20 No.6, 页码: 545-550
作者:  Zhao, Jin-Ge;  Liu, Jian-Dong;  Shen, Peng-Fei;  Tang, Xin;  Sun, Guang-Xi
收藏  |  浏览/下载:8/0  |  提交时间:2019/02/25


©版权所有 ©2017 CSpace - Powered by CSpace